TTK Healthcare Q2 FY27 standalone PAT Rs 222.97 cr; revenue Rs 233.38 cr

What the numbers show

• Net margin was 95.54% of revenue, against 10.02% a year earlier.

• Revenue from operations (quarter ended 30/09/2026): Rs 233.38 cr vs Rs 203.57 cr (30/09/2025)

• Total income (quarter ended 30/09/2026): Rs 252.12 cr vs Rs 222.54 cr (30/09/2025)

• Total expenses (quarter ended 30/09/2026): Rs 232.39 cr vs Rs 201.29 cr (30/09/2025)

• Cost of materials consumed (quarter ended 30/09/2026): Rs 67.44 cr vs Rs 48.05 cr (30/09/2025)

• Purchase of stock-in-trade (quarter ended 30/09/2026): Rs 46.93 cr vs Rs 48.77 cr (30/09/2025)

• Changes in inventories of finished goods, work-in-progress and stock-in-trade (quarter ended 30/09/2026): Rs (0.6653) cr vs Rs 1.03 cr (30/09/2025)

• Employee benefits expense (quarter ended 30/09/2026): Rs 46.38 cr vs Rs 41.10 cr (30/09/2025)

• Finance costs (quarter ended 30/09/2026): Rs 0.5855 cr vs Rs 0.8384 cr (30/09/2025)

• Depreciation and amortization expense (quarter ended 30/09/2026): Rs 2.16 cr vs Rs 2.21 cr (30/09/2025)

• Other expenses (quarter ended 30/09/2026): Rs 69.54 cr vs Rs 59.27 cr (30/09/2025)

• Profit / (loss) before exceptional items and tax (quarter ended 30/09/2026): Rs 19.74 cr vs Rs 21.30 cr (30/09/2025)

• Exceptional items (quarter ended 30/09/2026): Rs 248.20 cr vs Rs 0.00 cr (30/09/2025)

• Profit / (loss) before tax (quarter ended 30/09/2026): Rs 267.94 cr vs Rs 21.30 cr (30/09/2025)

• Tax expense – Current tax (quarter ended 30/09/2026): Rs 44.65 cr vs Rs 5.35 cr (30/09/2025)

• Tax expense – Deferred tax (quarter ended 30/09/2026): Rs 0.3138 cr vs Rs 0.1757 cr (30/09/2025)

• Tax relating to earlier years (quarter ended 30/09/2026): Rs 0.00 cr vs Rs (4.62) cr (30/09/2025)

• Profit / (loss) for the period from continuing operations (quarter ended 30/09/2026): Rs 222.97 cr vs Rs 20.39 cr (30/09/2025)

• Profit / (loss) for the period (quarter ended 30/09/2026): Rs 222.97 cr vs Rs 20.39 cr (30/09/2025)

• Earnings per equity share – Basic (for continuing operations, not annualised) (quarter ended 30/09/2026): Rs 157.80 vs Rs 14.43 (30/09/2025)

• Earnings per equity share – Diluted (for continuing operations, not annualised) (quarter ended 30/09/2026): Rs 157.80 vs Rs 14.43 (30/09/2025)

For Q2 FY27 (quarter ended 30/09/2026), TTK Healthcare Limited’s standalone revenue from operations, as per the statement of financial results, was Rs 233.38 cr compared with Rs 203.57 cr in the corresponding quarter ended 30/09/2025. Total income rose to Rs 252.12 cr from Rs 222.54 cr over the same period.

Total expenses increased to Rs 232.39 cr in the quarter ended 30/09/2026 from Rs 201.29 cr a year earlier, with cost of materials consumed at Rs 67.44 cr (vs Rs 48.05 cr) and employee benefits expense at Rs 46.38 cr (vs Rs 41.10 cr). Other expenses were Rs 69.54 cr versus Rs 59.27 cr in the corresponding prior quarter.

Profit before exceptional items and tax for the quarter ended 30/09/2026 was Rs 19.74 cr compared with Rs 21.30 cr a year earlier. The company reported exceptional items of Rs 248.20 cr in the current quarter, against Rs 0.00 cr in the quarter ended 30/09/2025, leading to profit before tax of Rs 267.94 cr versus Rs 21.30 cr.

After current tax of Rs 44.65 cr, deferred tax of Rs 0.3138 cr and no tax relating to earlier years in the current quarter (vs Rs 5.35 cr current tax, Rs 0.1757 cr deferred tax and Rs (4.62) cr tax relating to earlier years in the prior quarter), profit for the period from continuing operations stood at Rs 222.97 cr, up from Rs 20.39 cr in the corresponding quarter. Basic and diluted earnings per equity share for continuing and discontinued operations (not annualised) were Rs 157.80 for the quarter ended 30/09/2026, compared with Rs 14.43 for the quarter ended 30/09/2025, as disclosed in the statement of financial results.